SureTrader Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 7/27/2016 6:52:19 PM - Followers: 1302 - Board type: Free - Posts Today: 33

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
Announced FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#202935  Sticky Note ABT’s CEO spends $46M cash to buy/exercise 1.28M DewDiligence 07/27/16 04:41:18 PM
#202933  Sticky Note KDMN closes -19% on first day of trading. DewDiligence 07/27/16 04:10:59 PM
#202923  Sticky Note FTC backs TEVA-AGN deal with conditions: DewDiligence 07/27/16 02:44:04 PM
#202920  Sticky Note So a new familial ALS gene was just discovered: biomaven0 07/27/16 01:05:05 PM
#202911  Sticky Note Way way way down overall, but SQNM TRIPLED Jonathan Robinson 07/27/16 09:40:11 AM
#202908  Sticky Note TauRx phase-3 trial in AD misses primary endpoints: DewDiligence 07/27/16 09:04:08 AM
#202939   AMGN—2Q16 Neupogen sales fell 23% YoY—due, in part, DewDiligence 07/27/16 06:52:19 PM
#202938   ABT addendum: The sheer size of the CEO’s DewDiligence 07/27/16 06:46:58 PM
#202936   No, I haven't followed PETX closely enough to DewDiligence 07/27/16 06:07:24 PM
#202935   ABT’s CEO spends $46M cash to buy/exercise 1.28M DewDiligence 07/27/16 04:41:18 PM
#202934   Hello Dew, gdollasign 07/27/16 04:39:26 PM
#202933   KDMN closes -19% on first day of trading. DewDiligence 07/27/16 04:10:59 PM
#202932   EXAS selling 8.05M shares at unspecified price: DewDiligence 07/27/16 04:04:30 PM
#202931   ABT might be off the hook for ALR DewDiligence 07/27/16 03:58:11 PM
#202930   "The only way to produce credible data in north40000 07/27/16 03:22:39 PM
#202929   Feuerstein's take on AVXL data: DewDiligence 07/27/16 03:16:25 PM
#202928   Curious, is it not, that most of that north40000 07/27/16 03:14:15 PM
#202926   TEVA now expects AGN deal to close next week: DewDiligence 07/27/16 03:04:18 PM
#202925   BMRN—Matt Herper opines on GT data in hemophilia-A: DewDiligence 07/27/16 03:02:17 PM
#202924  Restored AVXL -32% on those data (eom). DewDiligence 07/27/16 02:51:09 PM
#202923   FTC backs TEVA-AGN deal with conditions: DewDiligence 07/27/16 02:44:04 PM
#202922   May be this is the case with AD. linhdtu 07/27/16 01:15:16 PM
#202921   AVXL: 2nd of 2 releases from AAIC re north40000 07/27/16 01:05:29 PM
#202920   So a new familial ALS gene was just discovered: biomaven0 07/27/16 01:05:05 PM
#202919   TauRx fails AD. As an ex elan cult linhdtu 07/27/16 12:41:59 PM
#202918   Sqnm, this smells and smacks of vulture capitalism linhdtu 07/27/16 12:28:24 PM
#202916   ZIOP/XON new patent app- Vectors Conditionally Expressing Therapeutic DFRAI 07/27/16 11:07:02 AM
#202915   CLBS implements 1:10 reverse split effective after the DewDiligence 07/27/16 10:42:03 AM
#202914   ZIOP - even Juno is coming around to DFRAI 07/27/16 10:08:48 AM
#202913   ZIOP - ahead of the CAR pack - DFRAI 07/27/16 09:49:06 AM
#202912   LH-SQNM is the 8th-highest premium among the table DewDiligence 07/27/16 09:43:40 AM
#202911   Way way way down overall, but SQNM TRIPLED Jonathan Robinson 07/27/16 09:40:11 AM
#202910   Recent Biotech Buyouts of Publicly Traded Companies DewDiligence 07/27/16 09:25:27 AM
#202909   LH-SQNM PR: DewDiligence 07/27/16 09:23:22 AM
#202908   TauRx phase-3 trial in AD misses primary endpoints: DewDiligence 07/27/16 09:04:08 AM
#202907   $LH LabCorp To Acquire $SQNM for $2.40/share. $302M ronpopeil 07/27/16 07:06:34 AM
#202906   TKAI -70% on termination of CRPC phase-3 for mcbio 07/26/16 09:44:36 PM
#202905   CUV.AX / CLVLY / CLVLF - Well not mcbio 07/26/16 09:42:09 PM
#202904   I doubt that I can add anything to IanFromSI 07/26/16 09:14:47 PM
#202903   Ariad (ARIA): I expect Biomaven has discovered a biotech_researcher 07/26/16 08:40:26 PM
#202901   MORRISTOWN, N.J., July 26, 2016 (GLOBE NEWSWIRE) -- buckiii2 07/26/16 06:28:48 PM
#202900   Top 25 oncology products in 2015 http://www.mmm-online.com/therapeutic-focus/top Titan V 07/26/16 06:14:24 PM
#202899   TBRA's future seems cloudy, at best. bladerunner1717 07/26/16 06:01:20 PM
#202898   OT: if you live a hard and fast JohnWayne 07/26/16 05:40:48 PM
#202896   If only Bavi could be obtained over the xrymd 07/26/16 05:27:40 PM
#202895   Sounds good but for the fights...I just returned north40000 07/26/16 05:13:00 PM
#202894   KDMN IPOs 7.19M* shares @$12.00 (down from initial DewDiligence 07/26/16 05:12:04 PM
#202893   Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the dosing Dr_Thorfin 07/26/16 05:06:19 PM
#202892   REPH +56%/AH on first phase-3 IV-Meloxicam trial in DewDiligence 07/26/16 05:01:15 PM
#202891   EGRX—The "carrot" is submitting more analysis to the DewDiligence 07/26/16 04:39:37 PM
#202890   EGRX will presumably try the carrot first, and Bickema 07/26/16 04:35:28 PM
#202889   EGRX will presumably try the carrot first, and DewDiligence 07/26/16 04:28:35 PM
#202888   LOL re Kadmon’s business plan: The idea, according DewDiligence 07/26/16 04:27:33 PM
#202887   >>Seems hard to believe. biomaven0 07/26/16 04:25:02 PM
#202886   Do you think Eagle can come up with Bickema 07/26/16 04:24:55 PM
#202885   heres how to stave off AD masterlongevity 07/26/16 04:08:36 PM
PostSubject